367 related articles for article (PubMed ID: 33031863)
1. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection.
Bentivegna E; Alessio G; Spuntarelli V; Luciani M; Santino I; Simmaco M; Martelletti P
Am J Infect Control; 2021 May; 49(5):640-642. PubMed ID: 33031863
[TBL] [Abstract][Full Text] [Related]
2. The interplay of SARS-CoV-2 and
Khanna S; Kraft CS
Future Microbiol; 2021 Apr; 16():439-443. PubMed ID: 33847139
[TBL] [Abstract][Full Text] [Related]
3. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients.
Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A
Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250
[TBL] [Abstract][Full Text] [Related]
4. Healthcare-associated
Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
[No Abstract] [Full Text] [Related]
5. Clostridioides difficile infection (CDI) during the COVID-19 pandemic.
Spigaglia P
Anaerobe; 2022 Apr; 74():102518. PubMed ID: 35063599
[TBL] [Abstract][Full Text] [Related]
6. Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022.
Maldonado-Barrueco A; Moreno-Ramos F; Díaz-Pollán B; Loeches-Yagüe B; Rico-Nieto A; García-Rodríguez J; Ruiz-Carrascoso G
Anaerobe; 2024 Apr; 86():102836. PubMed ID: 38428802
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection.
Merchante N; Chico P; Márquez-Saavedra E; Riera G; Herrero R; González-de-la-Aleja P; Aller AI; Rodríguez JC; Rodríguez-Fernández M; Ramos JM; Trigo-Rodríguez M; Merino E
Anaerobe; 2022 Jun; 75():102579. PubMed ID: 35500744
[TBL] [Abstract][Full Text] [Related]
8. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
9. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
10. Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.
Barker AK; Alagoz O; Safdar N
Clin Infect Dis; 2018 Apr; 66(8):1192-1203. PubMed ID: 29112710
[TBL] [Abstract][Full Text] [Related]
11. Healthcare-associated Clostridium difficile infection: role of correct hand hygiene in cross-infection control.
Ragusa R; Giorgianni G; Lupo L; Sciacca A; Rametta S; La Verde M; Mulè S; Marranzano M
J Prev Med Hyg; 2018 Jun; 59(2):E145-E152. PubMed ID: 30083622
[TBL] [Abstract][Full Text] [Related]
12. Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial
Ponce-Alonso M; Sáez de la Fuente J; Rincón-Carlavilla A; Moreno-Nunez P; Martínez-García L; Escudero-Sánchez R; Pintor R; García-Fernández S; Cobo J
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):406-410. PubMed ID: 32895065
[TBL] [Abstract][Full Text] [Related]
13. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre.
Voona S; Abdic H; Montgomery R; Clarkson A; Twitchell H; Hills T; Briggs S; Crooks C; Monaghan TM
Anaerobe; 2022 Feb; 73():102479. PubMed ID: 34801705
[TBL] [Abstract][Full Text] [Related]
15. Implication of COVID-19 pandemic on the incidence of
Karampatakis T; Tsergouli K; Kandilioti E; Nikopoulou A; Katsifa H; Kachrimanidou M
J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37195744
[No Abstract] [Full Text] [Related]
16. Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data.
Endo K; Mizuno K; Takeuchi M; Kawakami K
Anaerobe; 2023 Feb; 79():102693. PubMed ID: 36623703
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile control measures: current and future methods for prevention.
Mejia-Chew C; Dubberke ER
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504
[TBL] [Abstract][Full Text] [Related]
18. Clostridioides difficile infection in the COVID-19 era: old and new problems.
Spigaglia P
Pol Arch Intern Med; 2021 Feb; 131(2):118-120. PubMed ID: 33641318
[No Abstract] [Full Text] [Related]
19. Our experience with 80 cases of SARS-CoV-2-Clostridioides difficile co-infection: An observational study.
Birlutiu V; Dobritoiu ES; Lupu CD; Herteliu C; Birlutiu RM; Dragomirescu D; Vorovenci A
Medicine (Baltimore); 2022 Jul; 101(27):e29823. PubMed ID: 35801777
[TBL] [Abstract][Full Text] [Related]
20. Can Emergency Department Wait Times Predict Rates of Hospital-Acquired Clostridioides difficile Infection? A Study of Acute Care Facilities in New York State.
Durant DJ; Young CG
J Patient Saf; 2022 Mar; 18(2):e508-e513. PubMed ID: 34009865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
